IMMURON LIMITED Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019
IMMURON LIMITED (IMRN) reported Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019 of 0.14 AUD/shares for the 12-month period ending 2025-06-30, per its 20-F filed 2025-09-25.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019 · last filed 2025-09-25
USD/shares
| Period end | Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019 | Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019 12 month |
|---|---|---|
| 2023-06-30 | $1.85 20-F · filed 2023-09-28 | |
| 2022-11-25 | $1.85 20-F · filed 2023-09-28 |
AUD/shares
| Period end | Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019 12 month | Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019 12 month as first filed |
|---|---|---|
| 2025-06-30 | 0.14 AUD/shares 20-F · filed 2025-09-25 | |
| 2024-06-30 | 0.25 AUD/shares 20-F · filed 2025-09-25 | 0.19 AUD/shares 20-F · filed 2024-10-01 |
| 2023-06-30 | 0.12 AUD/shares 20-F · filed 2025-09-25 | |
| 2022-06-30 | 0.25 AUD/shares 20-F · filed 2024-10-01 |